tiprankstipranks
Purple Biotech (PPBT)
NASDAQ:PPBT
US Market

Purple Biotech (PPBT) Financial Statements

Compare
984 Followers

Purple Biotech Financial Overview

Purple Biotech's market cap is currently $7.32M. The company's EPS TTM is $-5.178; its P/E ratio is ―; Purple Biotech is scheduled to report earnings on February 5, 2025, and the estimated EPS forecast is $-0.22. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 195.80K$ -910.00K$ -320.00K$ 1.00M
Gross Profit$ 0.00$ -196.00$ -1.11M$ -551.00K$ 765.00K
Operating Income$ -11.01M$ 22.27M$ -22.60M$ -17.93M$ 12.61M
EBITDA$ -7.05M$ -22.23M$ -21.49M$ -17.52M$ -28.41M
Net Income$ -7.24M$ -19.88K$ -20.82M$ -18.46M$ -12.40M
Balance Sheet
Cash & Short-Term Investments$ 8.52M$ 15.41M$ 32.11M$ 47.20M$ 57.80M
Total Assets$ 37.04M$ 44.30M$ 54.62M$ 70.20M$ 83.80M
Total Debt$ 183.00K$ 351.00K$ 515.00K$ 749.00K$ 895.00K
Net Debt$ -7.22M$ -14.14M$ -14.52M$ -10.14M$ -10.35M
Total Liabilities$ 4.13M$ 10.01M$ 7.52M$ 5.09M$ 4.05M
Stockholders' Equity$ 32.86M$ 34.21M$ 46.91M$ 64.83M$ 79.39M
Cash Flow
Free Cash Flow$ -14.37M$ -19.93M$ -16.96M$ -15.19M$ -12.25M
Operating Cash Flow$ -14.37M$ -19.93M$ -16.73M$ -15.07M$ -12.09M
Investing Cash Flow$ 509.00K$ 13.88M$ 19.91M$ 13.41M$ -49.59M
Financing Cash Flow$ 6.77M$ 5.45M$ 1.11M$ 1.51M$ 68.49M
Currency in USD

Purple Biotech Earnings and Revenue History

Purple Biotech Debt to Assets

Purple Biotech Cash Flow

Purple Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis